<DOC>
	<DOCNO>NCT02844049</DOCNO>
	<brief_summary>Obsessive-Compulsive Disorder ( OCD ) among disable psychiatric disorder 40 % patient resistant standard pharmacological psychotherapy approach 10 % show severe disability require institutionalization . These resistant patient may benefit new surgical therapeutic approach Deep Brain Stimulation ( DBS ) use high frequency stimulation specific cerebral region modulate neural network . Although promising , result need nevertheless replicate confirm within large cohort patient consider different main objective , instead clinical improvement . Indeed , despite positive treatment response , adaptive functioning quality life may continue negatively impacted OCD . Thus beyond symptom reduction , health-related quality life ( QoL ) represent important objective treatment , include individual 's functional status individual 's subjective perception impact illness patient 's life . STN DBS induce significant clinical improvement , may proportional QoL gain . Consequently , QoL appear well outcome target come study clinical improvement alone . THe investigator thus propose prospective study assess QoL change resistant OCD patient STN DBS+BMT versus Best Medical Treatment ( BMT ) 12 month , order ass DBS induce gain QoL BMT-managed patient versus BMT alone .</brief_summary>
	<brief_title>European Study Quality Life Resistant OCD Patients Treated STN DBS</brief_title>
	<detailed_description>The study focus innovative therapeutic strategy ( DBS ) original objective , quality life , consider well reflect impact therapeutic strategy . Moreover , study help define predictive biomarkers /biosignatures response STN DBS OCD .</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>OCD &gt; 5 year YBOCS &gt; 25 and/or YBOCS subscale &gt; 15 GAF &lt; 45 3 document SRI trial , include clomipramine ( 1012 week adequate dose ) SRI augmentation &gt; 4 week least one antipsychotic one following : lithium , clonazepam Adequate trial CBT ( Exposure Therapy Response Prevention ) ( intolerance &gt; 15 session ) Ability provide inform consent Hoarding ( OCD symptom ) OCD poor insight ( BABS score &gt; 12 ) Lifetime diagnosis psychosis bipolar disorder ; Substance abuse dependence within previous six month ; Baseline Montgomery Asberg ( MADRS ) suicidality item ( item 10 ) score &gt; 2 ; Current DSM5 personality disorder Cluster A ( e.g. , paranoid schizotypal personality disorder ) B ( e.g. , borderline antisocial personality disorder ) ; Brain pathology , moderate mark cerebral atrophy , stroke , tumor previous neurosurgical procedure ( i.e . capsulotomy etc ) , history cognitive impairment cognitive deterioration ( Addenbrooke 's Cognitive Examination ACE score &lt; 80 ) . Contraindications surgery , anaesthesia , MRI compulsory hospitalization/ care ; pregnant nursing patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>Quality Life</keyword>
</DOC>